Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The development of anti-interleukin-2 antibodies in patients treated with recombinant human interleukin-2 (IL-2).

The development of anti-interleukin-2 antibodies in patients treated with recombinant human interleukin-2 (IL-2). J Clin Immunol. 1986 Nov; 6(6):481-90.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.